AVBP

Arrivent Biopharma Inc

13.64

+1.41+11.53%

After Hours: 13.52 -0.12 -0.85%19:30 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE12.40/12.23

TODAY RANGE12.00-13.88

VOL1.40M

MARKET CAP672.56M

52 WEEK RANGE11.36-35.83

AVG VOL (3M)1.27M

% TURNOVER2.56%

TURNOVER--

P/E (TTM)-3.7152

% RANGE15.33%

EPS(TTM)-3.6714

P/E(FORWARD)-3.3035

P/B1.797

BVPS7.59

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP611.05M

SHARES OUTSTANDING49.31M

NEXT EARNINGS11/09-11/13

FREE FLOAT44.80M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·4d ago
ArriVent BioPharma Consensus Price Target Increased 14.29% to $25.96
Dow Jones·10/27 13:40
ArriVent BioPharma Is Maintained at Buy by Guggenheim
TipRanks·10/27 11:20
ArriVent Biopharma price target raised to $30 from $18 at Guggenheim
TipRanks·10/26 19:25
Analyst Ups Price Target to $21 and Reiterates Buy on Strong ARR-217 Data and Growth Catalysts
TipRanks·10/26 19:00
ArriVent Biopharma price target raised to $21 from $18 at Truist
TipRanks·10/26 18:50
ArriVent Biopharma price target raised to $25 from $18 at Oppenheimer
TipRanks·10/26 15:15
ArriVent Biopharma announces initial Phase 1 results for ARR-217
Dow Jones·10/26 11:21
ArriVent BioPharma Shares Gain on Study Data for Gastrointestinal Cancer Treatment
Seeking Alpha·10/26 10:55
At a glance: stocks gapping up premarket
NASDAQ·10/26 10:53
ArriVent BioPharma, Inc. Announces Initial Phase 1 Data for CDH17-Targeted ADC ARR-217
TipRanks·10/26 10:32
ArriVent BioPharma Reports Promising ARR-217 Phase 1 Data
TipRanks·10/26 09:45
Jeet Mukherjee Reiterates Buy on ARR-217 as Early Colorectal Cancer Data Strengthen Risk‑Reward Profile and Support Unchanged $29 Price Target
TipRanks·10/26 00:30
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Merck & Company (MRK)
TipRanks·10/25 19:40
ArriVent cancer data support ‘best-in-class’ potential, says Clear Street
Dow Jones·10/20 17:54
ArriVent BioPharma Is Maintained at Buy by B. Riley Securities

Same Industry

Name/Symbol

Change%

Price

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

Moderna

MRNA

+5.27%

254.19

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

ARCT

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.